OGOREK ANTHONY JOSEPH /NY/ /ADV - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
OGOREK ANTHONY JOSEPH /NY/ /ADV ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
3,6000.0%0.00%
Q2 2023$10.0%3,6000.0%0.00%
Q1 2023$1
-66.7%
3,6000.0%0.00%
-100.0%
Q4 2022$3
-99.9%
3,6000.0%0.00%
-50.0%
Q3 2022$5,000
-28.6%
3,6000.0%0.00%
-33.3%
Q2 2022$7,000
-12.5%
3,6000.0%0.00%0.0%
Q1 2022$8,000
-50.0%
3,6000.0%0.00%
-57.1%
Q4 2021$16,000
-40.7%
3,6000.0%0.01%
-41.7%
Q3 2021$27,000
-20.6%
3,6000.0%0.01%
-20.0%
Q2 2021$34,000
+17.2%
3,6000.0%0.02%
+7.1%
Q1 2021$29,000
+20.8%
3,6000.0%0.01%
+7.7%
Q4 2020$24,0003,6000.01%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders